{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:25:17Z","timestamp":1788639917597,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["0320200170"],"award-info":[{"award-number":["0320200170"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2021R1A2C2004874"],"award-info":[{"award-number":["2021R1A2C2004874"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.chest.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T09:45:27Z","timestamp":1636883127000},"page":"1201-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab"],"prefix":"10.1016","volume":"161","author":[{"given":"Jun Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Il","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongwon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Suk","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.chest.2021.11.007_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.chest.2021.11.007_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.chest.2021.11.007_bib3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2021.11.007_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.chest.2021.11.007_bib5","doi-asserted-by":"crossref","first-page":"1242.e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"issue":"suppl 4","key":"10.1016\/j.chest.2021.11.007_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.chest.2021.11.007_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","article-title":"Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients","volume":"46","author":"Bienvenu","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.chest.2021.11.007_bib9","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","article-title":"Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib10","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/fmb.09.116","article-title":"Current understanding of Pneumocystis immunology","volume":"5","author":"Kelly","year":"2010","journal-title":"Future Microbiol"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.1200861","article-title":"Memory CD4+ T\u00a0cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina","volume":"190","author":"Kelly","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.chest.2021.11.007_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1165\/rcmb.2015-0356OC","article-title":"Transcriptomic analysis reveals significant B lymphocyte suppression in corticosteroid-treated hosts with Pneumocystis pneumonia","volume":"56","author":"Hu","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib14","doi-asserted-by":"crossref","first-page":"L291","DOI":"10.1152\/ajplung.00210.2018","article-title":"IL-10-producing B cells regulate Th1\/Th17-cell immune responses in Pneumocystis pneumonia","volume":"316","author":"Rong","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.chest.2021.11.007_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminhematol.2010.01.002","article-title":"Rituximab-associated infections","volume":"47","author":"Gea-Banacloche","year":"2010","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.chest.2021.11.007_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10428190902730219","article-title":"Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis","volume":"50","author":"Aksoy","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib17","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1038\/s41598-018-26743-4","article-title":"Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients","volume":"8","author":"Wei","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1378\/chest.13-0530","article-title":"Routine Pneumocystis pneumonia prophylaxis in patients treated with rituximab?","volume":"144","author":"Besada","year":"2013","journal-title":"Chest"},{"issue":"9237","key":"10.1016\/j.chest.2021.11.007_bib20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.chest.2021.11.007_bib22","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.chest.2021.11.007_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/bimj.201600223","article-title":"Modeling time-varying exposure using inverse probability of treatment weights","volume":"60","author":"Graff\u00e9o","year":"2018","journal-title":"Biom J"},{"issue":"27","key":"10.1016\/j.chest.2021.11.007_bib24","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.chest.2021.11.007_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.chest.2021.11.007_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-019-1996-6","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids: clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.chest.2021.11.007_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"8 suppl","key":"10.1016\/j.chest.2021.11.007_bib29","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jclinepi.2013.03.020","article-title":"Approaches to inverse-probability-of-treatment-weighted estimation with concurrent treatments","volume":"66","author":"Ellis","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2021.11.007_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2021.11.007_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122171","article-title":"Prophylaxis and treatment of Pneumocystis jiroveci pneumonia in lymphoma patients subjected to rituximab-contained therapy: a systemic review and meta-analysis","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.chest.2021.11.007_bib32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/ajh.24499","article-title":"Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy","volume":"91","author":"Barreto","year":"2016","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.chest.2021.11.007_bib33","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/IAI.03099-14","article-title":"Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia","volume":"83","author":"Elsegeiny","year":"2015","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.chest.2021.11.007_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/IAI.02639-14","article-title":"B\u00a0cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent","volume":"83","author":"Hoyt","year":"2015","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.chest.2021.11.007_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2004-08-3198","article-title":"B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis","volume":"106","author":"Dunleavy","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.chest.2021.11.007_bib36","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B\u00a0cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.chest.2021.11.007_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12882-020-01750-8","article-title":"Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab","volume":"21","author":"Kim","year":"2020","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.chest.2021.11.007_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03009742.2020.1762921","article-title":"Pneumocystis jirovecii pneumonia in patients treated for systemic autoimmune disorders: a retrospective analysis of patient characteristics and outcome","volume":"49","author":"Verhaert","year":"2020","journal-title":"Scand J Rheumatol"},{"issue":"30","key":"10.1016\/j.chest.2021.11.007_bib39","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221042914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221042914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:43:15Z","timestamp":1757925795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221042914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0012369221042914"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.007","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}